Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Release Pentasa in Ulcerative Colitis
NCT00603733Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Ferring Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00603733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603733.